| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hanley David C. | CHIEF TECHNICAL OPERATIONS | C/O NUVATION BIO, INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 21 Nov 2025 | 0001865826 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Options Exercise | $374,000 | +200,000 | +833% | $1.87 | 224,000 | 19 Nov 2025 | Direct | F1 |
| transaction | NUVB | Class A Common Stock | Sale | $1,427,680 | -200,000 | -89% | $7.14 | 24,000 | 19 Nov 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Stock Option (Right to Buy) | Options Exercise | $0 | -200,000 | -40% | $0.000000 | 300,000 | 19 Nov 2025 | Class A Common Stock | 200,000 | $1.87 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. |
| F2 | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |